colistimethate sodium has been researched along with Sepsis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Eiam-Ong, S; Praditpornsilpa, K; Srisawat, N; Susantitaphong, P; Thammathiwat, T; Tiranathanagul, K | 1 |
| Chirla, D; Giri, SR; Kumar, PP; Panigrahy, N; Shaikh, FA | 1 |
| Chatterjee, M; Dutta, A; Majumdar, R; Mitra, P; Nag, SS | 1 |
| Brienza, N; Bruno, F; Coppolecchia, S; Dalfino, L; Miragliotta, G; Monno, R; Mosca, A; Puntillo, F; Spada, ML | 1 |
| Lipman, J; Roberts, JA | 1 |
| Baltopoulos, G; Boutzouka, E; Fousteri, M; Hroni, D; Markantonis, SL; Markou, N; Zidianakis, B | 1 |
6 other study(ies) available for colistimethate sodium and Sepsis
| Article | Year |
|---|---|
Clinical and subclinical acute kidney injury in multidrug-resistant septic patients treated with colistimethate sodium: Incidence and clinical outcomes.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asymptomatic Diseases; Biomarkers; Colistin; Creatinine; Drug Resistance, Multiple, Bacterial; Fatty Acid-Binding Proteins; Female; Humans; Incidence; Lipocalin-2; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Sepsis; Time Factors; Treatment Outcome | 2020 |
Safety and efficacy of intravenous colistin in children.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Creatinine; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prospective Studies; Sepsis | 2015 |
Intravenous Colistimethate Sodium in Neonatal Sepsis.
Topics: Administration, Intravenous; Colistin; Humans; Infant, Newborn; Neonatal Sepsis; Sepsis | 2016 |
High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome | 2012 |
Editorial commentary: Closing the loop--a colistin clinical study to confirm dosing recommendations from PK/PD modeling.
Topics: Anti-Bacterial Agents; Colistin; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Male; Sepsis | 2012 |
Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colistin; Critical Illness; Gram-Negative Bacterial Infections; Hemodiafiltration; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Sepsis; Serum; Time Factors | 2012 |